[ Author(Desc)] Title Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Gleim S, Stitham J, Tang WHo, Li H, Douville K, Chelikani P, Rade JJ, Martin KA, Hwa J.  2013.  Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysis. PLoS One. 8(6):e67314.
Gottlieb A, Altman RB.  2014.  Integrating systems biology sources illuminates drug action. Clin Pharmacol Ther. 95(6):663-9.
Goya J, Wong AK, Yao V, Krishnan A, Homilius M, Troyanskaya OG.  2015.  FNTM: a server for predicting functional networks of tissues in mouse. Nucleic Acids Res. 43(W1):W182-7.
Greene CS, Krishnan A, Wong AK, Ricciotti E, Zelaya RA, Himmelstein DS, Zhang R, Hartmann BM, Zaslavsky E, Sealfon SC et al..  2015.  Understanding multicellular function and disease with human tissue-specific networks. Nat Genet. 47(6):569-76.
Grevengoed TJ, Martin SA, Katunga L, Cooper DE, Anderson EJ, Murphy RC, Coleman RA.  2015.  Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function. J Lipid Res. 56(8):1572-82.
Griffin JL, Wang X, Stanley E.  2015.  Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics. Circ Cardiovasc Genet. 8(1):187-91.
Guo L, Worth AJ, Mesaros C, Snyder NW, Glickson JD, Blair IA.  2016.  Diisopropylethylamine/hexafluoroisopropanol-mediated ion-pairing ultra-high-performance liquid chromatography/mass spectrometry for phosphate and carboxylate metabolite analysis: utility for studying cellular metabolism. Rapid Commun Mass Spectrom. 30(16):1835-45.